BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2249117)

  • 1. Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability.
    Chapple CR; Parkhouse H; Gardener C; Milroy EJ
    Br J Urol; 1990 Nov; 66(5):491-4. PubMed ID: 2249117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the combination emepronium bromide/flavoxate and emepronium bromide in the treatment of detrusor instability.
    Aagaard J; Reuther K; Stimpel H
    Urol Int; 1983; 38(3):191-2. PubMed ID: 6868218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavoxate hydrochloride in the treatment of detrusor instability.
    Delaere KP; Michiels HG; Debruyne FM; Moonen WA
    Urol Int; 1977; 32(5):377-81. PubMed ID: 610033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesically administered ketoprofen in treatment of detrusor instability: cross-over study.
    Sprem M; Milicić D; Oresković S; Ljubojević N; Kalafatić D
    Croat Med J; 2000 Dec; 41(4):423-7. PubMed ID: 11063767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urodynamic studies on detrusor hyperreflexia. III. Clinical treatment of detrusor hyperreflexia by TURP, oral administration of flavoxate and prolonged bladder distension (author's transl)].
    Furuya S; Yokoyama E; Kumamoto Y; Tsukamoto T
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1597-604. PubMed ID: 7345197
    [No Abstract]   [Full Text] [Related]  

  • 7. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women.
    Robinson JM; Brocklehurst JC
    Br J Urol; 1983 Aug; 55(4):371-6. PubMed ID: 6349743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study.
    Martin MR; Schiff AA
    Br J Urol; 1984 Apr; 56(2):178-9. PubMed ID: 6388713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of detrusor hyperreflexia in multiple sclerosis: a double-blind, crossover clinical trial comparing methantheline bromide (Banthine), flavoxate chloride (Urispas) and meladrazine tartrate (Lisidonil).
    Hebjorn S
    Urol Int; 1977; 32(2-3):209-17. PubMed ID: 20683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flavoxate on hyperactive detrusor muscle.
    Jonas U; Petri E; Kissel J
    Eur Urol; 1979; 5(2):106-9. PubMed ID: 421699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic response of unstable bladder to flavoxate.
    Zanollo A; Catanzaro F
    Urol Int; 1980; 35(3):176-81. PubMed ID: 7385465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of flurbiprofen in detrusor instability.
    Cardozo LD; Stanton SL; Robinson H; Hole D
    Br Med J; 1980 Feb; 280(6210):281-2. PubMed ID: 6986948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture in the treatment of bladder instability.
    Philp T; Shah PJ; Worth PH
    Br J Urol; 1988 Jun; 61(6):490-3. PubMed ID: 3401657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence.
    Milani R; Scalambrino S; Carrera S; Pezzoli P; Ruffmann R
    J Int Med Res; 1988; 16(3):244-8. PubMed ID: 3044876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability.
    Cardozo LD; Stanton SL
    J Urol; 1979 Jul; 122(1):58-9. PubMed ID: 458990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavoxate treatment of micturition disorders accompanying benign prostatic hypertrophy: a double-blind placebo-controlled multicenter investigation.
    Dahm TL; Ostri P; Kristensen JK; Walter S; Frimodt-Møller C; Rasmussen RB; Nøhr M; Alexander N
    Urol Int; 1995; 55(4):205-8. PubMed ID: 8588267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofeedback in the treatment of detrusor instability.
    Cardozo L; Stanton SL; Hafner J; Allan V
    Br J Urol; 1978 Jun; 50(4):250-4. PubMed ID: 753471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to treatment of detrusor instability in relation to psychoneurotic status.
    Moore KH; Sutherst JR
    Br J Urol; 1990 Nov; 66(5):486-90. PubMed ID: 2249116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic perspective on the physiology of the lower urinary tract.
    Andersson KE; Hedlund P
    Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity.
    Kuo HC
    Urology; 2003 Mar; 61(3):550-4. PubMed ID: 12639645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.